Company: TXG
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0001770787-25-000031
Chunk: 1

Company: 10x Genomics, Inc.
Filing Date: 2025-05-08
Form: 8-K
Item: Item 2.05
Chunk 1
---
Item 2.05 Costs Associated with Exit or Disposal Activities

On May 6, 2025, to decrease its costs and adjust its organizational structure to align with its strategic priorities, the Company committed to a reduction in force that is expected to result in the termination of approximately 8% of the Company’s global workforce. In connection with the reduction in force, the Company currently estimates it will incur between $5.5 million and $6.5 million of costs consisting primarily of cash severance costs which the Company expects to recognize in the second quarter of 2025 and pay by the end of third quarter of 2025. The estimates of costs and expenses that the Company expects to incur in connection with the workforce reduction are subject to a number of assumptions and actual results may differ materially. The Company may also incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the workforce reduction.

Item 9.01 Financial Statements and Exhibits.